Search research articles
Contact Us
Filters
Showing results (281-290 of 524) with videos related to
Page
of 53
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer
Joshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.
Science Signaling
|
February 7, 2019
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
Arnaud Augert, Emily Eastwood, Ali H Ibrahim, et al.
Cancer Biology & Therapy
|
July 14, 2011
Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts
Yu-An Zhang, Anirban Maitra, Jer-Tsong Hsieh, et al.
Cancer Cell
|
January 8, 2013
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists
James Kim, Blake T Aftab, Jean Y Tang, et al.
NPJ Precision Oncology
|
July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2007
A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
Christopher G Azzoli, Lee M Krug, Vincent A Miller, et al.
Cancer Research
|
July 11, 2025
RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma
Alessandro M Mozzarelli, Antonio Cuevas-Navarro, Emily G Shuldiner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 31, 2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Paul K Paik, Charles M Rudin, Maria C Pietanza, et al.
Biorxiv : the Preprint Server for Biology
|
October 14, 2020
TMEM41B is a pan-flavivirus host factor
H-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, et al.
Cell
|
December 18, 2020
TMEM41B Is a Pan-flavivirus Host Factor
H-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, et al.
Page
of 53
Search research articles
Search
Showing results (281-290 of 524) with videos related to
Sort By:
Page
of 53
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer
Joshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.
Science Signaling
|
February 7, 2019
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
Arnaud Augert, Emily Eastwood, Ali H Ibrahim, et al.
Cancer Biology & Therapy
|
July 14, 2011
Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts
Yu-An Zhang, Anirban Maitra, Jer-Tsong Hsieh, et al.
Cancer Cell
|
January 8, 2013
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists
James Kim, Blake T Aftab, Jean Y Tang, et al.
NPJ Precision Oncology
|
July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2007
A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
Christopher G Azzoli, Lee M Krug, Vincent A Miller, et al.
Cancer Research
|
July 11, 2025
RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma
Alessandro M Mozzarelli, Antonio Cuevas-Navarro, Emily G Shuldiner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 31, 2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Paul K Paik, Charles M Rudin, Maria C Pietanza, et al.
Biorxiv : the Preprint Server for Biology
|
October 14, 2020
TMEM41B is a pan-flavivirus host factor
H-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, et al.
Cell
|
December 18, 2020
TMEM41B Is a Pan-flavivirus Host Factor
H-Heinrich Hoffmann, William M Schneider, Kathryn Rozen-Gagnon, et al.
Page
of 53